Defendants brand: Haegarda, Plaintiff Brands: CINRYZE, FIRAZYR, & KALBITOR: Shire ViroPharma v. CSL Behring
Law360, New York (April 10, 2017, 8:25 PM EDT) -- Shire ViroPharma Inc. on Monday hammered a Federal Trade Commission antitrust suit over alleged abuse of the U.S. Food and Drug Administration’s citizen petition process to delay generic competition, calling it procedurally improper and an affront to constitutional rights.